These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 25572169

  • 1. IgM MGUS associated with anti-MAG neuropathy: a single institution experience.
    Talamo G, Mir MA, Pandey MK, Sivik JK, Raheja D.
    Ann Hematol; 2015 Jun; 94(6):1011-6. PubMed ID: 25572169
    [Abstract] [Full Text] [Related]

  • 2. Immunostaining of skin biopsy adds no diagnostic value in MGUS-associated peripheral neuropathy.
    Al-Zuhairy A, Schrøder HD, Plesner T, Abildgaard N, Sindrup SH.
    J Neurol Sci; 2015 Feb 15; 349(1-2):60-4. PubMed ID: 25582978
    [Abstract] [Full Text] [Related]

  • 3. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.
    Kuijf ML, Eurelings M, Tio-Gillen AP, van Doorn PA, van den Berg LH, Hooijkaas H, Stork J, Notermans NC, Jacobs BC.
    Neurology; 2009 Sep 01; 73(9):688-95. PubMed ID: 19720975
    [Abstract] [Full Text] [Related]

  • 4. Prognosis of polyneuropathy due to IgM monoclonal gammopathy: a prospective cohort study.
    Niermeijer JM, Fischer K, Eurelings M, Franssen H, Wokke JH, Notermans NC.
    Neurology; 2010 Feb 02; 74(5):406-12. PubMed ID: 20124206
    [Abstract] [Full Text] [Related]

  • 5. Neuropathy associated with monoclonal gammopathies of undetermined significance.
    Gosselin S, Kyle RA, Dyck PJ.
    Ann Neurol; 1991 Jul 02; 30(1):54-61. PubMed ID: 1656848
    [Abstract] [Full Text] [Related]

  • 6. Antibodies to myelin-associated glycoprotein (anti-Mag) in IgM amyloidosis may influence expression of neuropathy in rare patients.
    Garces-Sanchez M, Dyck PJ, Kyle RA, Zeldenrust S, Wu Y, Ladha SS, Klein CJ.
    Muscle Nerve; 2008 Apr 02; 37(4):490-5. PubMed ID: 18236455
    [Abstract] [Full Text] [Related]

  • 7. IgM monoclonal gammopathy-associated neuropathies with different IgM specificity.
    Matà S, Borsini W, Ambrosini S, Toscani L, Barilaro A, Piacentini S, Sorbi S, Lolli F.
    Eur J Neurol; 2011 Aug 02; 18(8):1067-73. PubMed ID: 21261794
    [Abstract] [Full Text] [Related]

  • 8. Polyneuropathy and monoclonal gammopathy of undetermined significance (MGUS); update of a clinical experience.
    Matà S, Torricelli S, Barilaro A, Grippo A, Forleo P, Del Mastio M, Sorbi S.
    J Neurol Sci; 2021 Apr 15; 423():117335. PubMed ID: 33647732
    [Abstract] [Full Text] [Related]

  • 9. [Successful treatment with rituximab in two cases of IgM-monoclonal gammopathy of undetermined significance (MGUS) neuropathy].
    Koike M, Sugimoto K, Tusui M, Yahata Y.
    Rinsho Ketsueki; 2012 Apr 15; 53(4):450-4. PubMed ID: 22687979
    [Abstract] [Full Text] [Related]

  • 10. Long-term disability and prognostic factors in polyneuropathy associated with anti-myelin-associated glycoprotein (MAG) antibodies.
    Galassi G, Tondelli M, Ariatti A, Benuzzi F, Nichelli P, Valzania F.
    Int J Neurosci; 2017 May 15; 127(5):439-447. PubMed ID: 27188752
    [Abstract] [Full Text] [Related]

  • 11. Short and long-term effect of IVIg in demyelinating neuropathy associated with MGUS, experience of a monocentric study.
    Théaudin M, Lozeron P, Lacroix C, Chrétien P, Ducot B, Denier C, Adams D.
    Rev Neurol (Paris); 2011 Dec 15; 167(12):897-904. PubMed ID: 22023823
    [Abstract] [Full Text] [Related]

  • 12. Acute neurological worsening after Rituximab treatment in patients with anti-MAG neuropathy.
    Sala E, Robert-Varvat F, Paul S, Camdessanché JP, Antoine JC.
    J Neurol Sci; 2014 Oct 15; 345(1-2):224-7. PubMed ID: 25115501
    [Abstract] [Full Text] [Related]

  • 13. Comparison of IgM-MGUS and IgG-MGUS polyneuropathy.
    Simovic D, Gorson KC, Ropper AH.
    Acta Neurol Scand; 1998 Mar 15; 97(3):194-200. PubMed ID: 9531437
    [Abstract] [Full Text] [Related]

  • 14. Hospital population screening reveals overrepresentation of CD5(-) monoclonal B-cell lymphocytosis and monoclonal gammopathy of undetermined significance of IgM type.
    Voigtlaender M, Vogler B, Trepel M, Panse J, Jung R, Bokemeyer C, Bacher U, Binder M.
    Ann Hematol; 2015 Sep 15; 94(9):1559-65. PubMed ID: 26040471
    [Abstract] [Full Text] [Related]

  • 15. Prevalence, specificity and functionality of anti-ganglioside antibodies in neuropathy associated with IgM monoclonal gammopathy.
    Stork AC, Jacobs BC, Tio-Gillen AP, Eurelings M, Jansen MD, van den Berg LH, Notermans NC, van der Pol WL.
    J Neuroimmunol; 2014 Mar 15; 268(1-2):89-94. PubMed ID: 24529728
    [Abstract] [Full Text] [Related]

  • 16. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS.
    Suarez GA, Kelly JJ.
    Neurology; 1993 Jul 15; 43(7):1304-8. PubMed ID: 8327128
    [Abstract] [Full Text] [Related]

  • 17. Characterizing neuropathies associated with monoclonal gammopathy of undetermined significance (MGUS): a framework consistent with classifying injuries according to fiber size.
    Fisher MA, Wilson JR.
    Neurol Clin Neurophysiol; 2002 Jul 15; 2002(3):2-7. PubMed ID: 12028821
    [Abstract] [Full Text] [Related]

  • 18. [Neuropathy associated with dysglobulinemia and monoclonal gammopathy].
    Saito T.
    Nihon Rinsho; 1994 Nov 15; 52(11):2976-83. PubMed ID: 7996697
    [Abstract] [Full Text] [Related]

  • 19. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV, Harris S, Dispenzieri A, Cosio FG, Habermann TM, Stegall MD, Dean PG, Prieto M, Kyle RA, Rajkumar SV, Leung N.
    Am J Nephrol; 2012 Nov 15; 35(4):365-71. PubMed ID: 22473253
    [Abstract] [Full Text] [Related]

  • 20. Neuropathy and monoclonal gammopathy.
    Nobile-Orazio E.
    Handb Clin Neurol; 2013 Nov 15; 115():443-59. PubMed ID: 23931795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.